Related by context. All words. (Click for frequent words.) 77 mL/min/#.# m 2 75 nondiabetics 75 ejection fractions 74 glycated hemoglobin levels 73 CVD mortality 73 HbA1C levels 73 colorectal adenoma 73 serum creatinine levels 73 systolic dysfunction 73 binary restenosis 72 β blockers 72 REYATAZ r arm 72 % CI #.#-#.# [003] 72 nonfatal MI 72 hemoglobin A1c levels 72 elevated LDH 72 #mmHg [001] 71 HbA 1c levels 71 CYPHER Stent 71 paricalcitol 71 LV dysfunction 71 ischemia driven 71 NPH insulin 71 revascularizations 71 underwent CABG 71 advanced adenomas 71 postintervention 71 intima media thickness 71 preintervention 71 nicardipine 71 highest tertile 71 hepatorenal syndrome 71 lowest tertile 71 p = NS 71 nonobese 71 underwent resection 71 lispro 70 HBeAg negative patients 70 nondiabetic 70 MMSE scores 70 reinfarction 70 deep venous thromboses 70 % CI #.#-#.# [007] 70 unfractionated heparin UFH 70 PREZISTA r arm 70 normotensive 70 underwent surgical resection 70 XIENCE V demonstrated 70 lipid lowering agents 70 advanced adenoma 70 tertile 70 thyrotropin levels 70 stage IIIb IV 70 severe exacerbations 70 sirolimus stent 70 paclitaxel eluting stents 70 μmol L 70 adjunctive placebo 70 NNT = 70 Hb A1C 70 HbA 1c 70 Baseline characteristics 70 graft occlusion 70 comparator arm 70 diastolic blood pressures 70 Subgroup analysis 70 pT3 69 % CI #.#-#.# [008] 69 TAXUS Express Stent 69 tertiles 69 Doxil ® 69 biochemical relapse 69 relapsed MM 69 glycosylated hemoglobin HbA1c 69 lopinavir r arm 69 Operative mortality 69 eplerenone 69 baseline serum creatinine 69 confidence interval #.#-#.# 69 nonischemic 69 Stent thrombosis 69 oxycodone CR 69 morphometric vertebral fractures 69 everolimus eluting stents 69 nonmetastatic 69 preserved ejection fraction 69 Complication rates 69 #.#mg/dL 69 ALT elevation 69 CR nPR 69 euthyroid 69 HbA1c levels 69 salmeterol fluticasone 69 serum calcium levels 69 macrovascular events 69 NYHA functional class 69 postoperative mortality 69 postoperative complication 69 insulin detemir 69 MADRS score 69 serum urate levels 69 arterial thromboembolic events 69 HBeAg seroconversion 69 oral diclofenac 69 PLX STROKE targeting 69 atherogenic dyslipidemia 69 aldosterone antagonist 69 pulmonary dysfunction 69 hemodynamically significant 69 MACCE 69 Fasting blood glucose 69 KRAS mutations occur 69 perioperatively 69 fluvastatin 68 ß blockers 68 mm Hg diastolic 68 acute cholecystitis 68 multivariable adjusted 68 pCR 68 TEAEs 68 NMIBC 68 NHANES III 68 candesartan cilexetil 68 carotid IMT 68 Flu Cy 68 titrated glipizide 68 fasting triglyceride levels 68 elevated fasting glucose 68 dalteparin 68 liver transplant recipients 68 definite stent thrombosis 68 posttransplant 68 carotid artery intima media 68 oxycodone IR 68 coronary stenosis 68 ipsilateral stroke 68 nondiabetic subjects 68 elevated triglyceride levels 68 leukocyte count 68 serum triglycerides 68 nonobese patients 68 pretransplant 68 #.#/#.# mmHg [001] 68 serum phosphate 68 dose atorvastatin 68 elevated troponin 68 posttreatment 68 perioperative complications 68 mm Hg systolic 68 elevated LDL cholesterol 68 LV ejection fraction 68 locoregional recurrence 68 atorvastatin #mg 68 mild renal insufficiency 68 #.#mmol L [002] 68 serum uric acid 68 NATRECOR R 68 lymphocytosis 68 impaired glucose metabolism 68 HBeAg 68 nonfatal myocardial infarction MI 68 umol L 68 underwent liver transplantation 68 hip BMD 68 p = ns 68 flutamide 68 preoperative PSA 68 diastolic BP 68 patients undergoing CABG 68 irbesartan 68 intravenous diuretics 68 CC genotype 68 Taxus Stent 68 CLA supplementation 68 beta blocker therapy 68 mcg QD 68 CrCl 68 QTcF 68 mcg BID 68 echocardiographic parameters 68 HOMA IR 68 hormone receptor negative 68 thrombocytopenic 68 baseline HbA1c 68 rFVIIa 68 serum phosphate levels 68 Avandia Actos 68 MMSE score 68 diabetes mellitus DM 68 periprocedural 68 tolterodine ER 68 angiographic outcomes 67 triglyceride concentrations 67 mg BID dose 67 pamidronate 67 alanine aminotransferase ALT 67 leukocyte counts 67 achieved CCyR 67 nadroparin 67 methotrexate monotherapy 67 elevated serum creatinine 67 radial artery grafts 67 pulmonary capillary wedge 67 elevated creatinine 67 elevated hsCRP 67 intact parathyroid hormone 67 isolated systolic hypertension 67 nonvertebral fractures 67 SGRQ 67 glycated hemoglobin 67 carotid artery blockage 67 ATACAND 67 recurrent venous thromboembolism 67 achieved ACR# 67 retransplantation 67 malignant neoplasm 67 dyslipidaemia 67 lumbar spine BMD 67 hsCRP levels 67 symptomatic VTE 67 HER2 expression 67 ischemic cardiomyopathy 67 recurrent acute pancreatitis 67 recurrent glioblastoma multiforme 67 onset diabetes mellitus 67 carotid intima media 67 comorbid illnesses 67 IOP lowering 67 liver histology 67 undergone radical prostatectomy 67 alanine aminotransferase 67 p = .# [002] 67 pegylated liposomal doxorubicin 67 mmHg diastolic 67 P = .# 67 generalized edema 67 #mg/day [001] 67 rimonabant #mg 67 antihypertensive therapy 67 ximelagatran 67 multivariate adjustment 67 carotid stenosis 67 NYHA Class II 67 papillary renal cell carcinoma 67 CI #.#-#.# [001] 67 mEq L 67 oral hypoglycemic agents 67 unstable angina pectoris 67 serum selenium 67 Fasting glucose 67 oral hypoglycemic agent 67 oral antidiabetic medication 67 follicular lymphomas 67 unresectable tumors 67 mmol l 67 quetiapine risperidone 67 receiving ISENTRESS 67 systolic blood pressures 67 parous women 67 serum lipid levels 67 troponin T 67 PSADT 67 gross hematuria 67 pravastatin therapy 67 mIU L 67 nonfasting triglyceride levels 67 BENICAR HCT 67 albumin excretion 67 systolic hypertension 67 serum calcium 67 Thal Dex 67 VADT 67 Univariate analysis 67 preoperative chemotherapy 67 resected pancreatic cancer 67 glomerular filtration 67 undergoing coronary artery 67 albumin excretion rate 67 μg L 67 serum concentrations 67 advanced neoplasia 67 symptomatic intracranial 67 baseline Hb 67 CIMZIA TM certolizumab pegol 67 PSA nadir 67 neutrophil counts 67 artery stenosis 67 % CI #.#-#.# [006] 67 PASI scores 67 CCyR 67 univariate analysis 67 hemoglobin A1c HbA1c 67 macroalbuminuria 67 chlorthalidone 67 Plasma concentrations 67 hypercholesterolemic patients 67 neurodevelopmental impairment 67 aspirin clopidogrel 66 fasting glucose levels 66 perioperative mortality 66 p = .# [001] 66 nonsignificant difference 66 thromboembolic complications 66 unresectable HCC 66 HIV HCV coinfected 66 diameter stenosis 66 eosinophil count 66 noncardiac 66 DAS# CRP 66 recurrent VTE 66 myocardial infarctions 66 beta carotene supplementation 66 elevated ALT 66 % Confidence Interval 66 tirofiban 66 nmol l 66 left ventricular systolic 66 bezafibrate 66 acarbose 66 gm dl 66 IDDM 66 pancreatic adenocarcinoma 66 tHcy 66 Ishak fibrosis score 66 leucopenia 66 biphasic insulin aspart 66 detemir 66 mmol liter 66 noncardiovascular mortality 66 undetectable HBV DNA 66 pT2 66 angiographically 66 Serum creatinine 66 aminotransferases 66 oral Hycamtin 66 stable angina 66 ertapenem 66 glycated hemoglobin HbA1c 66 carotid artery stenting CAS 66 salmeterol HFA MDI 66 subclinical hypothyroidism 66 infliximab monotherapy 66 polyp recurrence 66 daily subcutaneous injections 66 affective psychosis 66 beta blocker atenolol 66 nonvertebral fracture 66 p ≤ 66 cilostazol 66 mutated KRAS 66 x ULN 66 aspartate aminotransferase 66 rizatriptan 66 interquartile range 66 COPD exacerbation 66 Breslow thickness 66 serum triglyceride levels 66 chlorambucil 66 cryptogenic 66 femoral neck BMD 66 myocardial infarction stroke 66 histological subtype 66 NATRECOR ® 66 revascularization procedures 66 TT genotype 66 PRADAXA #mg 66 sitosterol 66 abnormal p# biomarker 66 myocardial infarction MI 66 statin monotherapy 66 SGPT 66 antiretroviral naïve 66 glomerular filtration rate 66 intravesical therapy 66 Fasting plasma glucose 66 placebo dexamethasone 66 hypophosphatemia 66 prednisone prednisolone 66 PaO 2 66 DAS# remission 66 visceral metastases 66 #Gy 66 adjunctive ABILIFY 66 dapagliflozin plus 66 blood glucose concentrations 66 colon rectal 66 haematologic 66 endometrial hyperplasia 66 cerebral infarction 66 rosuvastatin #mg 66 diastolic pressures 66 mL/min/#.# m2 66 thromboembolic 66 BMI ≥ 66 isoprostane 66 transaminase elevations 66 Hypotension 66 LVEF 66 QRS duration 66 serum leptin 66 pmol L 66 nonfatal stroke 66 microangiopathy 66 segment binary restenosis 66 complete cytogenetic response 66 paroxysmal AF 66 renal cell carcinomas 66 nondepressed 66 fasting serum 66 plasma lipids 66 coronary revascularization 66 XIENCE V PROMUS Stent 66 lipid lowering medications 66 postoperative AF 66 titrated glipizide plus 66 certolizumab 65 atazanavir ritonavir 65 RYGB 65 enalapril 65 Heterozygous Familial Hypercholesterolemia 65 lamivudine monotherapy 65 multivariate analyzes 65 histologic subtype 65 bypass graft CABG surgery 65 aspartate aminotransferase AST 65 cardiac dysfunction 65 hypercholesterolaemia 65 protein excretion 65 interleukin IL -6 65 estimated GFR 65 baseline FEV 65 Postoperative complications 65 diastolic hypertension 65 lymphocyte count 65 hydroxyvitamin D concentrations 65 multivessel disease 65 zoledronate 65 fibrinolysis 65 #mmHg [002] 65 systolic BP 65 Pioglitazone 65 CYPHER ® 65 fluorouracil leucovorin 65 non valvular atrial 65 nadolol 65 endoscopic remission 65 biochemical recurrence 65 univariate analyzes 65 nmol liter 65 μg liter 65 glulisine 65 hepatic resection 65 clomipramine 65 adrenalectomy 65 mcg albinterferon alfa 2b 65 hyperlipidaemia 65 EDSS scores 65 hypertension diabetes mellitus 65 radical nephrectomy 65 abacavir lamivudine 65 subclinical hyperthyroidism 65 OGTT 65 oral antidiabetes 65 nonobstructive CAD 65 cinacalcet 65 receiving prophylactic anticoagulation 65 heterozygotes 65 thromboembolism 65 Arch Intern Med 65 timepoints 65 linoleic acid LA 65 plasma homocysteine 65 prostate cancer CaP 65 acromegalic patients 65 severe renal impairment 65 NIHSS 65 primary patency 65 HBeAg positive patients 65 metformin monotherapy 65 overt nephropathy 65 Insulin sensitivity 65 occlusive disease 65 triacylglycerol concentrations 65 elevated IOP 65 tenecteplase 65 ng dL 65 bisoprolol 65 transferrin saturation 65 p = #.# [003] 65 percutaneous transluminal coronary angioplasty 65 triglyceride concentration 65 argatroban 65 Adjuvant chemotherapy 65 postprocedure 65 nontraumatic 65 urolithiasis 65 postprandial glycemia 65 TAXUS Stent 65 poor metabolizers 65 Patency 65 fractional shortening 65 creatinine levels 65 + PH# 65 #OHD levels 65 thiazide diuretics 65 ELBW infants 65 serum estradiol 65 underwent radical prostatectomy 65 hippocampal volumes 65 LVSD 65 nodal metastasis 65 androgen suppression 65 macrovascular disease 65 myocardial infarctions MIs 65 CI -#.# 65 serum IGF 65 -#.# mg dL [002] 65 NSTE ACS 65 serum aminotransferase levels 65 #mg/dl 65 infarct size 65 cranial irradiation 65 serum urate 65 NYHA class 65 IFN beta 65 IPAH 65 undergoing CABG 65 hepatocellular carcinomas 65 moderate renal impairment 65 low dose Iluvien 65 multivariable analysis 65 cerebrovascular accident 65 IFN alfa 65 neurologic outcomes 65 comorbid conditions 65 undergoing peritoneal dialysis 65 elevated transaminases 65 abdominal irradiation 65 transaminase levels 65 intracranial hemorrhage ICH 65 postoperative morbidity 65 OPCAB 65 tolvaptan 65 metabolic parameters 65 prospectively defined 65 olmesartan 65 underwent radical cystectomy 65 FOLPI 65 vitreous floaters 65 fasting insulin 65 glycosylated hemoglobin 65 Hb A1c 65 glargine 65 idiopathic PAH 65 cerebrovascular events 65 metastatic malignant 65 lipid lowering drugs 65 BARACLUDE ® 65 chemoradiation therapy 65 refractory ischemia 65 loop diuretics 65 extrapyramidal symptoms 65 EDSS score 65 -#.# log# 65 endarterectomy 65 Homocysteine levels 65 nonoperative treatment 65 diuretic chlorthalidone 65 TAXUS p value 65 salpingo oophorectomy 65 ACR# responses 65 Hp2 2 65 SGOT 65 atherosclerotic renal artery stenosis 65 noninferior 65 tumor histology 65 rCBF 65 neurologic complications 65 arterial thickening 65 normothermic 65 ml kg 65 estimated glomerular filtration 65 clinically localized prostate 65 left ventricular dysfunction 65 intracerebral haemorrhage 65 receiving SIMPONI 65 CI #.#-#.# [002] 65 serum sodium levels 65 infarcts 65 prospectively stratified 65 hepatic cirrhosis 65 rebleeding 65 Kaplan Meier analysis 65 elevated uric acid 65 endometrial thickness 65 hypertension hypercholesterolemia 65 #mg BID [001] 65 underwent coronary angiography 65 prolonged QT interval 65 venlafaxine XR 65 T1DM 65 serum parathyroid hormone 65 % CI #.#-#.# [004] 65 hyperphenylalaninemia HPA due 64 NYHA Class III 64 #.#ng/ml 64 quetiapine Seroquel 64 invasive lobular 64 severe mitral regurgitation 64 Cypher Stent 64 GOUT 64 typical antipsychotics 64 normoxic 64 leiomyomas 64 Mg Uk 64 baseline LDH 64 specific antigen PSA 64 obstructive coronary artery 64 adiponectin concentrations 64 insulin glulisine 64 plasma triglycerides 64 Ramipril 64 nonfatal myocardial infarction 64 FOLFOX4 64 cTnI 64 severe renal insufficiency 64 autonomic dysfunction 64 hematopoietic cancers 64 somatostatin analog 64 CTEPH 64 statistically significant p = 64 FOSRENOL ® 64 nonpregnant women 64 allogeneic HSCT 64 valvular disease 64 adjuvant tamoxifen 64 undergoing radical cystectomy 64 Apidra ® 64 intracerebral hemorrhage ICH 64 azilsartan medoxomil 64 -#.# ± [002] 64 postoperative chemotherapy 64 gestational hypertension 64 stenoses 64 -#.# mg dL [001] 64 nulliparous women 64 histologically confirmed 64 renal artery stenosis 64 perioperative morbidity 64 reduce serum phosphate 64 Crohn Disease Activity 64 serum homocysteine 64 idraparinux 64 perimenopausal women 64 mucosal inflammation 64 skeletal metastases 64 tipranavir r 64 sodium nitroprusside 64 antiarrhythmic drug 64 total cholesterol triglycerides 64 hemoglobin Hb 64 folinic acid 64 nmol 64 invasive ductal 64 P ≤ 64 Papillary 64 squamous histology 64 CYP#D# inhibitor 64 sleeve lobectomy 64 progressive dyspnea 64 Folfox 64 amoxicillin clavulanate 64 NSTEMI 64 serum GGT 64 silent ischemia 64 desvenlafaxine succinate 64 Lipitor #mg 64 serum ferritin 64 BRCA1 mutation carriers 64 Carotid Revascularization Endarterectomy vs. 64 SSc 64 oncologic outcomes 64 statistical significance p 64 chronic hemodialysis 64 5-FU/LV 64 bioavailable testosterone 64 creatinine clearance 64 hypogonadal men 64 de novo lesions 64 g dl 64 Infusion Reactions Severe 64 hyperglycaemia 64 cerebrovascular accidents 64 LDL cholesterol concentrations 64 events MACE 64 pooled comparator 64 Hazard Ratio 64 liver metastasis 64 abacavir Ziagen 64 tapentadol ER 64 distensibility 64 hemoglobin concentrations 64 fosamprenavir 64 sirolimus eluting stent 64 Subgroup analyzes 64 creatinine ratio 64 rosuvastatin Crestor 64 lacunar 64 ductal breast cancer 64 FluCAM arm 64 proliferative retinopathy 64 hours postdose 64 vaso occlusive crisis 64 sumatriptan naproxen sodium 64 adenomatous 64 mediastinitis 64 GH deficiency 64 Am J Cardiol 64 hepatic enzymes 64 intraobserver 64 antihypertensive medications 64 sulfonylurea metformin 64 urine albumin 64 coronary blockages 64 #ng/ml 64 symptomatic carotid stenosis 64 subtrochanteric 64 underwent percutaneous coronary 64 Thiazolidinediones 64 SORT OUT III 64 #mg/day [002] 64 glycemia 64 arterial oxygen saturation 64 Coronary Artery Bypass Graft 64 pg mL 64 hypoglycemic events 64 hypoperfusion 64 T1c 64 HbA1C 64 artery occlusion 64 SUVmax 64 doxorubicin cyclophosphamide 64 benazepril 64 splenectomized 64 pg ml 64 Exclusion criteria 64 SCr 64 VT VF 64 Index CDAI 64 T2 lesion volume 64 mIU ml 64 corticosteroid dose 64 coronary calcification 64 adriamycin 64 dose statin therapy 64 N telopeptide 64 nonsignificant 64 hyperlipemia 64 hyperlipidemia hypertension 64 nonischemic cardiomyopathy 64 myocardial infarction ventricular fibrillation 64 HNSCC 64 ezetimibe simvastatin 64 hematologic toxicity 64 hypoglycemic episodes 64 intracranial atherosclerosis 64 TMP SMX 64 μg kg 64 abdominal adiposity 64 inversely associated 64 mitoxantrone plus 64 hemodilution 64 progression TTP 64 coinfected patients 64 carotid artery thickness 64 T2DM 64 nephron sparing surgery 64 thiazide diuretic 64 prostate carcinoma 64 portal vein thrombosis 64 chest radiographs 64 Non inferiority 64 CK MB 64 nmol L. 64 postop 64 leukocytosis 64 arteriolar 64 comorbid depression 64 Viread Emtriva Sustiva 64 elevated triglycerides 64 CHD mortality 64 cyclophosphamide methotrexate 64 anticoagulants blood thinners 64 neurologic progression 64 4mg/kg 64 hepatic metastases 64 antiangiogenic therapy 64 multivariate Cox 64 dysglycemia 64 gliclazide 64 octreotide LAR 64 hydroxyvitamin D levels 64 pyelonephritis 64 Lovaza ® 64 obese postmenopausal 64 labetalol 64 urinary albumin 64 atherothrombotic disease 64 HBeAg negative 64 cytopenias 64 estramustine 64 8mg/kg 64 carotid plaque 64 preeclamptic 64 chronic thromboembolic pulmonary 64 chorioamnionitis 64 Calcium intake 64 mixed hyperlipidemia 64 Prospective Randomized Trial 64 gallstone disease 64 CIMZIA ™ 64 achieved mucosal healing 64 retrospective cohort 64 symptomatic intracerebral hemorrhage 64 vertebral fracture 64 renal dysfunction 64 decompensated heart failure 64 aged ≥ 64 apolipoprotein B 64 CHD CVD 64 lumbar spine bone 64 levosimendan 64 symptomatic ischemic 64 mm Stent 64 Postoperatively 64 colorectal liver metastases 64 hypercholesterolemic 64 asymptomatic carotid stenosis 64 INCB# [003] 64 systolic function 64 bone marrow reticulin deposition 64 ARCOXIA 64 BMI z 64 Hazard Ratio HR 63 LNG IUS 63 cytoreduction 63 de novo AML 63 ruboxistaurin 63 A1c levels 63 undergoing coronary angiography 63 metastatic GIST 63 periprocedural MI 63 dose Iluvien 63 cerebral infarctions 63 CP CPPS 63 carotid endarterectomy CEA 63 ACUITY trial 63 virologic breakthrough 63 lung metastases 63 ischemic lesions 63 confidence intervals CIs 63 pravastatin Pravachol 63 gene polymorphism 63 #mg dose [002] 63 reintervention 63 extracapsular extension 63 pancreatic resection 63 sirolimus eluting stents 63 NNRTI resistance 63 nitroprusside 63 â ‰ ¥ 63 HDL cholesterol triglycerides 63 lymphatic cancers 63 #mg/dL [002] 63 adjuvant radiotherapy 63 fraction LVEF 63 haemorrhagic stroke 63 cardiovascular mortality 63 Erythropoietic therapies may 63 undetectable PSA 63 MetS 63 cardiovascular calcification 63 #mg/dL [001] 63 pioglitazone HCl 63 nonalcoholic steatohepatitis 63 allogeneic hematopoietic stem cell 63 acute myocardial infarctions 63 mg/m2 dose 63 pulmonary artery banding 63 STN stimulation 63 fasting plasma 63 anastomotic leak 63 everolimus eluting stent 63 aneurysmal subarachnoid hemorrhage 63 Index CDAI score 63 Non Alcoholic Steatohepatitis 63 hepatectomy 63 thromboprophylaxis 63 TAXUS Liberte Long 63 primary hypercholesterolemia 63 β blocker 63 hypervolemic 63 salmeterol fluticasone propionate 63 #mg doses [002] 63 metformin sulphonylurea 63 colorectal neoplasia 63 TAVR 63 systemic corticosteroid 63 confidence interval CI 63 systemic embolism 63 oral antidiabetic 63 HSCT 63 circulating EPCs 63 sotalol 63 HGPIN 63 hemodialysis patients 63 renal artery stenting 63 T1a 63 ziprasidone 63 mild renal impairment 63 gm dL 63 pentoxifylline 63 daunorubicin 63 DAS# scores 63 microvascular complications 63 severe hypoglycaemia 63 primary aldosteronism 63 laboratory abnormalities 63 virologic failure 63 mL kg 63 Adjunctive 63 mg ustekinumab 63 Ischemic 63 aminotransferase levels 63 glycaemia 63 anemia hemoglobin 63 H. pylori eradication 63 bypass grafting 63 fluticasone salmeterol 63 cardiovascular morbidity 63 decompensated cirrhosis 63 adenoma recurrence 63 Orthostatic hypotension 63 glimepiride 63 venlafaxine Effexor 63 amisulpride 63 elevated lipase 63 hypertensives 63 conventional angiography 63 aldosterone antagonists 63 active comparator 63 depressive symptomatology 63 neutropenic sepsis 63 coronary stenoses 63 candidemia 63 EURIDIS 63 metoprolol tartrate 63 undetectable viral 63 total abdominal hysterectomy 63 mycophenolate mofetil 63 hematological parameters 63 radiochemotherapy 63 Ferinject R 63 PUFA intake 63 % CI #.#-#.# [001] 63 Insulin detemir 63 reoperations 63 lactate dehydrogenase LDH 63 insulin lispro 63 BPS IC 63 FDA defined valvulopathy 63 transarterial 63 unfractionated heparin 63 acute myocardial infarction AMI 63 FUSILEV enhances 63 candesartan 63 AZT zidovudine Retrovir 63 serum phosphorus 63 obstructive CAD 63 thromboembolisms 63 splenectomized patients 63 myocardial fibrosis 63 ‰ ¥ 63 IM progesterone 63 glipizide plus 63 anthracycline taxane 63 highest quintile 63 annualized relapse 63 ARB telmisartan 63 arterial occlusion 63 landmark ATHENA trial 63 wedge resection 63 latent celiac disease 63 Triglyceride levels 63 glucose insulin 63 thrombocytosis 63 STRIDE PD 63 infarctions 63 detrusor overactivity